| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,998 |
4,038 |
$242K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,670 |
1,502 |
$110K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
257 |
230 |
$24K |
| T1015 |
Clinic visit/encounter, all-inclusive |
105 |
70 |
$15K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
221 |
216 |
$14K |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
52 |
15 |
$9K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,072 |
1,020 |
$9K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
151 |
149 |
$9K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
530 |
502 |
$8K |
| 87428 |
|
127 |
122 |
$7K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
26 |
26 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
13 |
13 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
88 |
44 |
$917.60 |
| 0011A |
|
24 |
24 |
$600.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
61 |
61 |
$596.24 |
| 0012A |
|
12 |
12 |
$480.00 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
21 |
17 |
$429.11 |
| 96127 |
|
79 |
77 |
$204.61 |
| 96160 |
|
58 |
54 |
$194.02 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
13 |
13 |
$85.94 |